Published in Nature on September 27, 2001
Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci U S A (2004) 12.89
Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc Natl Acad Sci U S A (2007) 5.95
Telomere diseases. N Engl J Med (2009) 5.68
Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc Natl Acad Sci U S A (2005) 4.64
Cancer in dyskeratosis congenita. Blood (2009) 4.28
Telomeres and telomerase in cancer. Carcinogenesis (2009) 4.28
Telomeres: protecting chromosomes against genome instability. Nat Rev Mol Cell Biol (2010) 4.23
The telomere syndromes. Nat Rev Genet (2012) 4.01
Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci U S A (2008) 3.86
Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood (2007) 3.86
Danazol Treatment for Telomere Diseases. N Engl J Med (2016) 3.39
Accelerated telomere erosion is associated with a declining immune function of caregivers of Alzheimer's disease patients. J Immunol (2007) 3.20
Telomeres and telomerase. Philos Trans R Soc Lond B Biol Sci (2004) 3.13
Human telomerase and its regulation. Microbiol Mol Biol Rev (2002) 3.11
TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes. Blood (2008) 3.02
The biogenesis and regulation of telomerase holoenzymes. Nat Rev Mol Cell Biol (2006) 2.94
Increased telomere fragility and fusions resulting from TRF1 deficiency lead to degenerative pathologies and increased cancer in mice. Genes Dev (2009) 2.91
The many facets of H/ACA ribonucleoproteins. Chromosoma (2005) 2.89
Telomeres, stem cells, senescence, and cancer. J Clin Invest (2004) 2.87
Telomere length homeostasis requires that telomerase levels are limiting. EMBO J (2006) 2.81
Principles of adoptive T cell cancer therapy. J Clin Invest (2007) 2.65
Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10. Hum Mol Genet (2007) 2.61
Syndromes of telomere shortening. Annu Rev Genomics Hum Genet (2009) 2.60
The structure and function of small nucleolar ribonucleoproteins. Nucleic Acids Res (2007) 2.50
Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia. Proc Natl Acad Sci U S A (2009) 2.44
Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita. Proc Natl Acad Sci U S A (2008) 2.37
Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature (2010) 2.36
Human diseases of telomerase dysfunction: insights into tissue aging. Nucleic Acids Res (2007) 2.34
Template boundary definition in mammalian telomerase. Genes Dev (2003) 2.30
TPP1 is required for TERT recruitment, telomere elongation during nuclear reprogramming, and normal skin development in mice. Dev Cell (2010) 2.24
Identification of ATPases pontin and reptin as telomerase components essential for holoenzyme assembly. Cell (2008) 2.20
Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita. Genes Dev (2006) 2.20
Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations. PLoS One (2010) 2.19
Mutations linked to dyskeratosis congenita cause changes in the structural equilibrium in telomerase RNA. Proc Natl Acad Sci U S A (2003) 2.18
Aplastic anemia. Curr Opin Hematol (2008) 2.17
Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells. Blood (2009) 2.12
Telomere length homeostasis. Chromosoma (2006) 2.12
Telomere and telomerase in stem cells. Br J Cancer (2007) 2.09
Telomere maintenance and human bone marrow failure. Blood (2008) 2.09
Advances in the understanding of dyskeratosis congenita. Br J Haematol (2009) 2.05
Determinants in mammalian telomerase RNA that mediate enzyme processivity and cross-species incompatibility. EMBO J (2003) 2.01
Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing. Proc Natl Acad Sci U S A (2004) 2.01
TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements. Blood (2008) 1.99
Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome. Blood (2007) 1.93
Architecture of human telomerase RNA. Proc Natl Acad Sci U S A (2011) 1.93
Natural and pharmacological regulation of telomerase. Nucleic Acids Res (2002) 1.92
Short telomeres are sufficient to cause the degenerative defects associated with aging. Am J Hum Genet (2009) 1.86
Distinct dosage requirements for the maintenance of long and short telomeres in mTert heterozygous mice. Proc Natl Acad Sci U S A (2004) 1.83
The genetics and clinical manifestations of telomere biology disorders. Genet Med (2010) 1.83
Functional characterization of novel telomerase RNA (TERC) mutations in patients with diverse clinical and pathological presentations. Haematologica (2007) 1.80
A molecular switch underlies a human telomerase disease. Proc Natl Acad Sci U S A (2002) 1.79
RNA-based affinity purification reveals 7SK RNPs with distinct composition and regulation. RNA (2007) 1.77
Constitutional telomerase mutations are genetic risk factors for cirrhosis. Hepatology (2011) 1.77
Engineered telomere degradation models dyskeratosis congenita. Genes Dev (2008) 1.72
The telomerase database. Nucleic Acids Res (2007) 1.69
Mammalian Rap1 controls telomere function and gene expression through binding to telomeric and extratelomeric sites. Nat Cell Biol (2010) 1.69
Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer. EMBO Mol Med (2012) 1.66
Telomere shortening impairs organ regeneration by inhibiting cell cycle re-entry of a subpopulation of cells. EMBO J (2003) 1.64
Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP1. Blood (2014) 1.64
Functional organization of repeat addition processivity and DNA synthesis determinants in the human telomerase multimer. Mol Cell Biol (2004) 1.63
Dyskeratosis congenita, stem cells and telomeres. Biochim Biophys Acta (2009) 1.62
Mutations in the SBDS gene in acquired aplastic anemia. Blood (2007) 1.62
Telomerase and idiopathic pulmonary fibrosis. Mutat Res (2011) 1.59
Telomeres and age-related disease: how telomere biology informs clinical paradigms. J Clin Invest (2013) 1.58
Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase. Blood (2011) 1.57
A spectrum of severe familial liver disorders associate with telomerase mutations. PLoS One (2009) 1.57
The mammalian transcriptome and the function of non-coding DNA sequences. Genome Biol (2004) 1.56
The effect of TERC haploinsufficiency on the inheritance of telomere length. Proc Natl Acad Sci U S A (2005) 1.56
Haploinsufficiency of mTR results in defects in telomere elongation. Proc Natl Acad Sci U S A (2002) 1.56
The telomerase activator TA-65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence. Aging Cell (2011) 1.55
A novel pseudoknot element is essential for the action of a yeast telomerase. Genes Dev (2003) 1.55
Telomerase insufficiency in rheumatoid arthritis. Proc Natl Acad Sci U S A (2009) 1.54
Two pathways recruit telomerase to Saccharomyces cerevisiae telomeres. PLoS Genet (2008) 1.52
The genetics of dyskeratosis congenita. Cancer Genet (2011) 1.50
InTERTpreting telomerase structure and function. Nucleic Acids Res (2010) 1.47
Pot1b deletion and telomerase haploinsufficiency in mice initiate an ATR-dependent DNA damage response and elicit phenotypes resembling dyskeratosis congenita. Mol Cell Biol (2008) 1.46
Expression of telomerase RNA template, but not telomerase reverse transcriptase, is limiting for telomere length maintenance in vivo. Mol Cell Biol (2004) 1.46
Telomeres and disease. EMBO J (2009) 1.41
Mutations in C16orf57 and normal-length telomeres unify a subset of patients with dyskeratosis congenita, poikiloderma with neutropenia and Rothmund-Thomson syndrome. Hum Mol Genet (2010) 1.40
Preferential maintenance of critically short telomeres in mammalian cells heterozygous for mTert. Proc Natl Acad Sci U S A (2002) 1.38
Identification and functional characterization of 2 variant alleles of the telomerase RNA template gene (TERC) in a patient with dyskeratosis congenita. Blood (2005) 1.37
A pathogenic dyskerin mutation impairs proliferation and activates a DNA damage response independent of telomere length in mice. Proc Natl Acad Sci U S A (2008) 1.37
Telomeres in cancer and ageing. Philos Trans R Soc Lond B Biol Sci (2011) 1.36
It all comes together at the ends: telomerase structure, function, and biogenesis. Mutat Res (2011) 1.36
Familial myelodysplastic syndromes: a review of the literature. Haematologica (2011) 1.36
Dyskeratosis congenita. FEBS Lett (2010) 1.36
Dyskeratosis congenita as a disorder of telomere maintenance. Mutat Res (2011) 1.35
Telomeres, lifestyle, cancer, and aging. Curr Opin Clin Nutr Metab Care (2011) 1.35
Structural elements required for association of the Saccharomyces cerevisiae telomerase RNA with the Est2 reverse transcriptase. Mol Cell Biol (2004) 1.32
Phenotypes in mTERT⁺/⁻ and mTERT⁻/⁻ mice are due to short telomeres, not telomere-independent functions of telomerase reverse transcriptase. Mol Cell Biol (2011) 1.31
Increased p53 activity does not accelerate telomere-driven ageing. EMBO Rep (2006) 1.30
Mitotic spindle destabilization and genomic instability in Shwachman-Diamond syndrome. J Clin Invest (2008) 1.29
Ancestral mutation in telomerase causes defects in repeat addition processivity and manifests as familial pulmonary fibrosis. PLoS Genet (2011) 1.29
Telomere phenotypes in females with heterozygous mutations in the dyskeratosis congenita 1 (DKC1) gene. Hum Mutat (2013) 1.27
Complex inheritance pattern of dyskeratosis congenita in two families with 2 different mutations in the telomerase reverse transcriptase gene. Blood (2007) 1.26
Telomere attrition due to infection. PLoS One (2008) 1.23
Bone marrow failure and the telomeropathies. Blood (2014) 1.23
Telomeres and immunological diseases of aging. Gerontology (2009) 1.22
Telomerase RNA deficiency in peripheral blood mononuclear cells in X-linked dyskeratosis congenita. Hum Genet (2004) 1.22
Dyskeratosis congenita: the first NIH clinical research workshop. Pediatr Blood Cancer (2009) 1.22
X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet (1998) 6.82
Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med (1995) 3.60
Esophageal dilation after laparoscopic adjustable gastric banding. Surg Endosc (2007) 3.27
Increased tumor establishment and growth after laparotomy vs laparoscopy in a murine model. Arch Surg (1995) 2.79
Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells Mol Dis (2001) 2.69
Dyskeratosis Congenita (DC) Registry: identification of new features of DC. Br J Haematol (1998) 2.43
Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int J Obes (Lond) (2009) 2.28
Dyskeratosis congenita: a genetic disorder of many faces. Clin Genet (2007) 2.23
Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance. Eur J Hum Genet (1997) 1.89
Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion. J Clin Invest (1997) 1.86
Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1. Br J Haematol (1999) 1.84
A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: a review. Leukemia (1995) 1.81
Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO J (1994) 1.80
X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene. Am J Hum Genet (1999) 1.80
Dyskeratosis congenita -- a disease of dysfunctional telomere maintenance. Curr Mol Med (2005) 1.78
Mutations downstream of the polyadenylation site of a Xenopus beta-globin mRNA affect the position but not the efficiency of 3' processing. Cell (1986) 1.76
Origin and spread of the glucose-6-phosphate dehydrogenase variant (G6PD-Mediterranean) in the Middle East. Am J Hum Genet (1990) 1.75
Dyskeratosis congenita: the diverse clinical presentation of mutations in the telomerase complex. Biochimie (2007) 1.72
Asthma severity, atopic status, allergen exposure and quality of life in elderly persons. Ann Allergy Asthma Immunol (2001) 1.70
The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss. J Clin Endocrinol Metab (2008) 1.67
The lack of toxicity of intravitreally administered triamcinolone acetonide. Am J Ophthalmol (1981) 1.61
Glucose-6-phosphate dehydrogenase deficiency. Baillieres Best Pract Res Clin Haematol (2000) 1.60
Somatic mutations in paroxysmal nocturnal hemoglobinuria: a blessing in disguise? Cell (1997) 1.54
A study of poliovaccination in infancy: excretion following challenge with live virus by children given killed or living poliovaccine. J Hyg (Lond) (1966) 1.51
Molecular cloning of the human Goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen. J Clin Invest (1992) 1.50
Increased sensitivity to complement and a decreased red blood cell life span in mice mosaic for a nonfunctional Piga gene. Blood (1999) 1.46
Heterogeneous spectrum of mutations in the Fanconi anaemia group A gene. Eur J Hum Genet (1999) 1.36
Transcripts, genes and bands in 315,000 base-pairs of Drosophila DNA. J Mol Biol (1983) 1.35
Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications. Pharmacogenetics (1997) 1.29
Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group. Blood (2000) 1.29
Postoperative cell mediated immune response is better preserved after laparoscopic vs open colorectal resection in humans. Surg Endosc (2003) 1.28
Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC). Hum Gene Ther (1999) 1.28
Postoperative immune function varies inversely with the degree of surgical trauma in a murine model. Surg Endosc (1997) 1.25
Skewed X-inactivation in carriers of X-linked dyskeratosis congenita. Blood (1997) 1.19
Polyadenylation of the Xenopus beta 1 globin mRNA at a downstream minor site in the absence of the major site and utilization of an AAUACA polyadenylation signal. EMBO J (1985) 1.16
A high-resolution microsatellite map of the mouse genome. Genome Res (1998) 1.14
Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase. A novel bifunctional enzyme in malaria parasites. Eur J Biochem (2001) 1.14
Evolutionary implications of a complex pattern of DNA sequence homology extending far upstream of the hsp70 genes at loci 87A7 and 87C1 in Drosophila melanogaster. J Mol Biol (1982) 1.13
X inactivation and somatic cell selection rescue female mice carrying a Piga-null mutation. Proc Natl Acad Sci U S A (1999) 1.12
Naturally occurring mutations define a novel function of the hepatitis B virus core promoter in core protein expression. J Virol (1998) 1.12
Both mutations in G6PD A- are necessary to produce the G6PD deficient phenotype. Hum Mol Genet (1992) 1.12
Specific defect in N-acetylglucosamine incorporation in the biosynthesis of the glycosylphosphatidylinositol anchor in cloned cell lines from patients with paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci U S A (1993) 1.11
Telomere length measurement can distinguish pathogenic from non-pathogenic variants in the shelterin component, TIN2. Clin Genet (2011) 1.08
FES-Cre targets phosphatidylinositol glycan class A (PIGA) inactivation to hematopoietic stem cells in the bone marrow. J Exp Med (2001) 1.08
Identification of novel DKC1 mutations in patients with dyskeratosis congenita: implications for pathophysiology and diagnosis. Hum Genet (2001) 1.08
The medical cost of drug abuse in an inner-city community. Am J Public Health (1979) 1.07
Contribution of cone photoreceptors and post-receptoral mechanisms to the human photopic electroretinogram. J Physiol (2004) 1.05
Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction. Blood (1996) 1.04
G6PD Canton a common deficient variant in South East Asia caused by a 459 Arg----Leu mutation. Nucleic Acids Res (1990) 1.04
Increased tumor establishment and growth after open vs laparoscopic surgery in mice may be related to differences in postoperative T-cell function. Surg Endosc (1999) 1.04
Better preservation of immune function after laparoscopic-assisted vs. open bowel resection in a murine model. Dis Colon Rectum (1996) 1.04
AIDS, hemophilia, and prevention efforts within a comprehensive care program. Am Psychol (1988) 1.03
The production and cost of ambulatory medical care in community health centers. Adv Health Econ Health Serv Res (1983) 1.03
The effects of elevated intraabdominal pressure, hypercarbia, and positioning on the hemodynamic responses to laparoscopic colectomy in pigs. Surg Endosc (1998) 1.02
Abnormal visual pathways in human albinos studied with visually evoked potentials. Exp Neurol (1979) 1.02
Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients. Aliment Pharmacol Ther (2006) 1.01
Tumor growth after laparotomy or laparoscopy. A preliminary study. Surg Endosc (1995) 1.00
Genomic organization of the X-linked gene (PIG-A) that is mutated in paroxysmal nocturnal haemoglobinuria and of a related autosomal pseudogene mapped to 12q21. Hum Mol Genet (1994) 1.00
The spectrum of somatic mutations in the PIG-A gene in paroxysmal nocturnal hemoglobinuria includes large deletions and small duplications. Blood Cells Mol Dis (1998) 1.00
Genetic heterogeneity of glucose-6-phosphate dehydrogenase deficiency revealed by single-strand conformation and sequence analysis. Am J Hum Genet (1993) 1.00
Polymorphic sites in the African population detected by sequence analysis of the glucose-6-phosphate dehydrogenase gene outline the evolution of the variants A and A-. Proc Natl Acad Sci U S A (1991) 0.99
Traumatic handling of the tumor independent of pneumoperitoneum increases port site implantation rate of colon cancer in a murine model. Surg Endosc (1998) 0.99
Dynamics of hematopoiesis in paroxysmal nocturnal hemoglobinuria (PNH): no evidence for intrinsic growth advantage of PNH clones. Leukemia (2002) 0.99
Dyskeratosis congenita. Cell Mol Life Sci (2003) 0.98
Preservation of immune response after laparoscopy. Surg Endosc (1994) 0.97
Port site tumor recurrence rates in a murine model of laparoscopic splenectomy decreased with increased experience. Surg Endosc (2000) 0.96
Molecular characterization of G6PD deficiency in Oman. Hum Hered (1997) 0.96
The dual pathogenesis of paroxysmal nocturnal hemoglobinuria. Curr Opin Hematol (1996) 0.96
Helium-neon laser irradiation at fluences of 1, 2, and 4 J/cm2 failed to accelerate wound healing as assessed by both wound contracture rate and tensile strength. Lasers Surg Med (1997) 0.95
Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C. J Viral Hepat (2013) 0.95
Cytogenetic and morphological abnormalities in paroxysmal nocturnal haemoglobinuria. Br J Haematol (2001) 0.95
Evidence for a continuous decline in haemopoietic cell function from birth: application to evaluating bone marrow failure in children. Br J Haematol (1999) 0.95
Reduced-intensity conditioning using fludarabine and antithymocyte globulin alone allows stable engraftment in a patient with dyskeratosis congenita. Acta Haematol (2010) 0.92
[Giant bladder calculus. Report of a clinical case]. Minerva Chir (1995) 0.92
IgD-receptor-positive human T lymphocytes. I. Modulation of receptor expression by oligomeric IgD and lymphokines. J Immunol (1990) 0.92
Production and characterization of lymphoblastoid cell lines with the paroxysmal nocturnal hemoglobinuria phenotype. Blood (1993) 0.92
Increased tumor establishment and growth after open vs laparoscopic bowel resection in mice. Surg Endosc (1998) 0.91
Amino acid substitutions at the dimer interface of human glucose-6-phosphate dehydrogenase that increase thermostability and reduce the stabilising effect of NADP. Eur J Biochem (1998) 0.90
Treatment of therapy-refractory B-lineage acute lymphoblastic leukemia with an apoptosis-inducing CD19-directed tyrosine kinase inhibitor. Clin Cancer Res (1999) 0.90
Early U.S. outcomes of laparoscopic gastric bypass versus laparoscopic adjustable silicone gastric banding for morbid obesity. Surg Endosc (2005) 0.90
1.4 Mb candidate gene region for X linked dyskeratosis congenita defined by combined haplotype and X chromosome inactivation analysis. J Med Genet (1998) 0.90
Mutations in the PIG-A gene causing paroxysmal nocturnal hemoglobinuria are mainly of the frameshift type. Blood (1995) 0.90
Successful unrelated umbilical cord blood transplantation in children with Shwachman-Diamond syndrome. Bone Marrow Transplant (2005) 0.90
Hospital-based group practice: does it change clinic patterns of care? J Gen Intern Med (1987) 0.90
Increased rates of pulmonary metastases following sham laparotomy compared to CO2 pneumoperitoneum and the inhibition of metastases utilizing perioperative immunomodulation and a tumor vaccine. Surg Endosc (2002) 0.90
Dyskeratosis congenita caused by a 3' deletion: germline and somatic mosaicism in a female carrier. Blood (1999) 0.89